@civitastherapeutics.com
Acorda is a biotechnology company developing and commercializing neurology therapies for Parkinson’s disease, migraine and multiple sclerosis
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Civitas Therapeutics, established in 1995, is a brand dedicated to improving the lives of individuals with multiple sclerosis (MS) and related cardiovascular and nervous system disorders. At Civitas, the focus is on developing therapies that restore function and provide hope for people with neurological disorders. Their mission is driven by the belief that these disorders are not just diseases to be treated, but individuals who deserve better lives.
Civitas offers a range of innovative products and research, including their ARCUS® Technology, AMPYRA® (dalfampridine), and INBRIJA® (levodopa inhalation powder). Through strategic partnerships and a grant program, Civitas is actively advancing research and education in the field of neurological disorders. They are committed to making tomorrow brighter for patients and their loved ones.
Visit their website to learn more about their products, resources, and ongoing initiatives
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online